Agile Capital Markets

Our latest deals : Domain Therapeutics ($42M series A), Ludocare (€4.2M Seed), Spine Innovations (M&A sell-side, un-disclosed amount), Neurofenix ($7M series A), Incepto (€27M series B)

About us

Agile Capital Markets is an investment banking boutique dedicated to life sciences companies

We offer special capabilities to address the critical issue of financing innovation in the healthcare arena. Agile Capital Markets has built a proven track record in raising funds, building strategies and structuring partnerships with a focus on value creation.

Agile Capital Markets stands out as a partner for funds and entrepreneurs in the field of healthcare and life sciences, seeking more than advisory and looking for strategic support and orientations while focusing on their businesses.

About us

Fundraising and growth financing

Tap into our network of investors to finance your life sciences company at every development stage. Agile Capital Markets has a proven expertise in raising capital in various forms and through innovative solutions (from 3 M€ to 60 M€, series A to C+).

Early-stage financing

Debt & equity, both public and private


Secondary offerings

M&A advisory

We provide high level and strong support on transactions, and execution of cross-border transactions.

Defining exit strategies

Fine-tuning valuation analysis

Identifying acquisition targets

Managing spin-out activities

Agile Capital Markets

Business Development & strategic partnerships

Our background as life science company executives gives us a unique edge in assisting companies in developing their businesses. Thanks to our international reach, we build up their partnership strategies with key players within the industry and bring value in their licensing process.

We leverage our expertise with a network of leading executives and industry experts to build your strategy in every aspect, scientific, medical, operational, legal and financial.

Identifying key players
key players

Introducing Strategic partners

Defining company’s equity story and development patterns
Defining company’s
equity story and

Negotiating partnerships and licensing agreements
and licensing

Regulatory Market Access
Market Access

Product positioning

Business Model